Tenet Healthcare Corporation $THC Position Trimmed by LSV Asset Management

LSV Asset Management lowered its stake in Tenet Healthcare Corporation (NYSE:THC) by 3.0% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 228,900 shares of the company’s stock after selling 7,000 shares during the period. LSV Asset Management owned approximately 0.26% of Tenet Healthcare worth $46,476,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of THC. William B. Walkup & Associates Inc. acquired a new position in shares of Tenet Healthcare in the 3rd quarter valued at $32,000. Canada Pension Plan Investment Board purchased a new stake in Tenet Healthcare during the second quarter valued at about $35,000. Westside Investment Management Inc. increased its position in shares of Tenet Healthcare by 100.0% in the third quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after acquiring an additional 96 shares in the last quarter. Trust Co. of Vermont purchased a new stake in shares of Tenet Healthcare in the 3rd quarter valued at approximately $41,000. Finally, Caitong International Asset Management Co. Ltd boosted its stake in Tenet Healthcare by 2,227.3% in the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 256 shares of the company’s stock worth $45,000 after purchasing an additional 245 shares during the period. 95.44% of the stock is owned by institutional investors and hedge funds.

Tenet Healthcare Stock Performance

THC stock opened at $230.90 on Friday. The company has a market capitalization of $20.29 billion, a price-to-earnings ratio of 14.91, a P/E/G ratio of 0.97 and a beta of 1.44. The firm has a 50 day moving average of $198.82 and a two-hundred day moving average of $194.69. The company has a quick ratio of 1.64, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $235.77.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, topping the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm had revenue of $5.53 billion for the quarter, compared to the consensus estimate of $5.47 billion. During the same period in the prior year, the business posted $3.44 earnings per share. The business’s quarterly revenue was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, equities analysts anticipate that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on THC shares. Weiss Ratings upgraded Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, December 29th. Jefferies Financial Group raised their price objective on Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a research report on Thursday. Barclays upped their target price on Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a report on Friday. Mizuho boosted their price objective on shares of Tenet Healthcare from $194.00 to $225.00 and gave the company an “outperform” rating in a research report on Friday, October 17th. Finally, Royal Bank Of Canada increased their target price on shares of Tenet Healthcare from $253.00 to $277.00 and gave the stock an “outperform” rating in a research report on Thursday. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $242.82.

Insiders Place Their Bets

In related news, Director Nadja West sold 2,178 shares of the business’s stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the completion of the sale, the director directly owned 28,480 shares in the company, valued at approximately $5,623,945.60. The trade was a 7.10% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.81% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.